{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "marketState": "REGULAR", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": 4.805729, "regularMarketPrice": 10.25, "exchange": "STO", "shortName": "IRLAB Therapeutics AB ser. A", "longName": "IRLAB Therapeutics AB (publ)", "messageBoardId": "finmb_418165027", "exchangeTimezoneName": "Europe/Stockholm", "market": "se_market", "regularMarketTime": 1684143765, "regularMarketDayHigh": 11.1, "regularMarketDayRange": "9.4 - 11.1", "regularMarketDayLow": 9.4, "regularMarketVolume": 38686, "regularMarketPreviousClose": 9.78, "bid": 10.0, "ask": 10.25, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 9.98, "averageDailyVolume3Month": 56758, "averageDailyVolume10Day": 49721, "fiftyTwoWeekLowChange": 1.5500002, "fiftyTwoWeekLowChangePercent": 0.17816095, "fiftyTwoWeekRange": "8.7 - 42.1", "fiftyTwoWeekHighChange": -31.849998, "fiftyTwoWeekHighChangePercent": -0.7565321, "fiftyTwoWeekLow": 8.7, "fiftyTwoWeekHigh": 42.1, "earningsTimestamp": 1683716340, "earningsTimestampStart": 1683716340, "earningsTimestampEnd": 1683716340, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.3, "epsForward": -2.7, "sharesOutstanding": 51788600, "bookValue": 5.607, "fiftyDayAverage": 10.548, "fiftyDayAverageChange": -0.29800034, "fiftyDayAverageChangePercent": -0.028251832, "twoHundredDayAverage": 25.47595, "twoHundredDayAverageChange": -15.22595, "twoHundredDayAverageChangePercent": -0.59765977, "marketCap": 530833152, "forwardPE": -3.7962961, "priceToBook": 1.8280721, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1488268800000, "priceHint": 2, "regularMarketChange": 0.47000027, "symbol": "IRLAB-A.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Arvid Wallgrens Backe 20", "city": "Gothenburg", "zip": "413 46", "country": "Sweden", "phone": "46 3 17 57 38 00", "website": "https://www.irlab.se", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "IRLAB Therapeutics AB (publ) develops drugs for the treatment of Parkinson's disease. The company develops Mesdopetam that is in phase IIb/III clinical studies for the treatment of dyskinesia; and Pirepemat, which is in phase IIb clinical trial for the treatment of Postural dysfunction. Its preclinical stage products include IRL942 and 1009 research programs for the treatment of neurodegenerative disorders and ageing; and IRL757 to treat apathy in neurological diseases. In addition, the company develops P003, a research project that develops drugs for the treatment of newly diagnosed Parkinson's disease. IRLAB Therapeutics AB (publ) was incorporated in 2013 and is based in Gothenburg, Sweden.", "fullTimeEmployees": 30, "companyOfficers": [{"maxAge": 1, "name": "Mr. Gunnar  Olsson", "age": 69, "title": "Interim CEO & Director", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": {"raw": 516666, "fmt": "516.67k", "longFmt": "516,666"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nicholas  Waters Ph.D.", "age": 60, "title": "Exec. VP and Head of R&D", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 1695814, "fmt": "1.7M", "longFmt": "1,695,814"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Viktor  Siewertz", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Clas  Sonesson Ph.D.", "age": 61, "title": "Chief Scientific Officer", "yearBorn": 1961, "fiscalYear": 2015, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peder  Svensson Ph.D.", "age": 60, "title": "Chief Information Officer and Director of Computational Chemistry & Biology", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Cecilia Tivert Stenberg B.Sc, B.Sc.", "age": 65, "title": "Head of Fin. & Human Resource and Director of Accounting & HR", "yearBorn": 1957, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Joakim  Tedroff M.D., Ph.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1961, "fiscalYear": 2017, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}